<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100279'>Ulcerative colitis</z:hpo> (UC) increases the risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), but the mechanisms involved in <z:hpo ids='HP_0002583'>colitis</z:hpo>-to-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> transition (CCT) are not well understood </plain></SENT>
<SENT sid="1" pm="."><plain>CCT may involve a <z:mp ids='MP_0001845'>inflammation</z:mp>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> progression sequence compared with the better characterized <z:mpath ids='MPATH_270'>adenoma</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> progression sequence associated with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>One common thread may be activating mutations in components of the Wnt/β-catenin signaling pathway, which occur commonly as early events in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>To examine this hypothesis, we evaluated possible associations between Wnt/β-catenin signaling and CCT based on the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell (<z:chebi fb="11" ids="17437,53115">CSC</z:chebi>) model </plain></SENT>
<SENT sid="4" pm="."><plain>Wnt/β-catenin immunostaining indicated that UC patients have a level of Wnt-pathway-active cells that is intermediate between <z:mpath ids='MPATH_458'>normal</z:mpath> colon and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>These UC cells exhibiting activation of the Wnt pathway constituted a major subpopulation (52% + 7.21) of the colonic epithelial cells positive for <z:chebi fb="1" ids="17478">aldehyde</z:chebi> dehydrogenase (ALDH), a putative marker of precursor colon <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> (pCCSC) </plain></SENT>
<SENT sid="6" pm="."><plain>We further fractionated this subpopulation of pCCSC using a Wnt pathway reporter assay </plain></SENT>
<SENT sid="7" pm="."><plain>Over successive passages, pCCSCs with the highest Wnt activity exhibited higher clonogenic and tumorigenic potential than pCCSCs with the lowest Wnt activity, thereby establishing the key role of Wnt activity in driving <z:chebi fb="11" ids="17437,53115">CSC</z:chebi>-like properties in these cells </plain></SENT>
<SENT sid="8" pm="."><plain>Notably, 5/20 single cell injections of high-Wnt pCCSC resulted in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> formation, suggesting a correlation with CCT </plain></SENT>
<SENT sid="9" pm="."><plain>Attenuation of Wnt/β-catenin in high-Wnt pCCSC by shRNA-mediated downregulation or pharmacological inhibition significantly reduced <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> rates </plain></SENT>
<SENT sid="10" pm="."><plain>Overall, the results of our study indicates (i) that early activation of Wnt/β-catenin signaling is critical for CCT and (ii) that high levels of Wnt/β-catenin signaling can further demarcate high-ALDH <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-initiating cells in the nondysplastic epithelium of UC patients </plain></SENT>
<SENT sid="11" pm="."><plain>As such, our findings offer plausible diagnostic markers and therapeutic target in the Wnt signaling pathway for early intervention in CCT </plain></SENT>
</text></document>